LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Critical Care Analyzer with Micro Capillary Sample Mode Provides Major Blood-Saving Benefit

By LabMedica International staff writers
Posted on 05 Oct 2023
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)
Image: FDA has cleared the Stat Profile Prime Plus analyzer for micro capillary sample mode (Photo courtesy of Nova Biomedical)

Excessive blood collection for lab tests in critically ill patients is known to be a significant cause of severe anemia and increased use of blood products. This, in turn, leads to longer hospital stays and higher mortality rates. Now, a novel blood gas analyzer featuring a micro capillary sample mode provides a major blood-saving benefit for the diagnostic testing of critically ill patients.

Nova Biomedical (Waltham, MA, USA) has received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a micro capillary sample mode on its Stat Profile Prime Plus Critical Care analyzer. This new feature allows Prime Plus to perform an 11-test panel using only 90 microliters of capillary blood. Alternatively, a comprehensive 22-test profile can be done with just 135 microliters of blood. This sampling mode enhances Prime Plus's existing capabilities for conserving blood during diagnostic testing and is now a standard feature on all Prime Plus analyzers.

The Stat Profile Prime Plus boasts a state-of-the-art test menu for critical care, featuring a range of tests including pH, PCO2, PO2, SO2%, Na, K, iCa, iMg, Cl, TCO2, glucose, lactate, creatinine, urea, hematocrit, hemoglobin, MCHC, estimated plasma volume, CO-Oximetry panel, and 34 calculated results. The simple, compact analyzer uses maintenance-free, replaceable cartridges for sensors and reagents, along with patented, maintenance-free, whole blood CO-Oximetry technology. The device's ability to use small-volume microcapillary blood collection tubes eliminates sample over-draws, dead volume, and waste typically associated with syringe or vacuum tube methods. Moreover, Prime Plus allows for scheduled bundling of tests, reducing the number of times blood needs to be drawn as well as the variety of containers used, thereby minimizing blood drawn for critical care testing.

"Prime Plus microsample volume and comprehensive test menu provide a major blood-saving benefit for diagnostic testing of critically ill patients,” said Terry Austin, Sales Product Line Manager for Prime Plus analyzer. “Prime Plus delivers gases, electrolytes, glucose, lactate, hematocrit, or any subset of these tests on just two drops (90 microliters) of blood. A basic metabolic panel of electrolytes, glucose, lactate, creatinine, urea, and hematocrit is available on 135 microliters, 1/50th the volume of blood needed for the same tests in the central laboratory."

Related Links:
Nova Biomedical

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more